Phase I trial of valproic acid and lenalidomide in patients with advanced cancer-Reference-Cited by-同舟云学术

Phase I trial of valproic acid and lenalidomide in patients with advanced cancer

Published:2015-02-10 Issue:4 Volume:75 Page:869-874
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Bilen Mehmet Asim,Fu Siqing,Falchook Gerald S.,Ng Chaan S.,Wheler Jennifer J.,Abdelrahim Maen,Erguvan-Dogan Basak,Hong David S.,Tsimberidou Apostolia M.,Kurzrock Razelle,Naing Aung

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2695-x.pdf

Reference28 articles.

1. Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013) Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. The Cochrane database of systematic reviews 6:CD010611. doi: 10.1002/14651858.CD010611

2. Chiu CT, Wang Z, Hunsberger JG, Chuang DM (2013) Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder. Pharmacol Rev 65(1):105–142. doi: 10.1124/pr.111.005512

3. Schwarz C, Volz A, Li C, Leucht S (2008) Valproate for schizophrenia. The Cochrane database of systematic reviews 3:CD004028. doi: 10.1002/14651858.CD004028.pub3

4. Haddad PM, Das A, Ashfaq M, Wieck A (2009) A review of valproate in psychiatric practice. Expert opin drug metabg toxicol 5(5):539–551. doi: 10.1517/17425250902911455

5. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276(39):36734–36741. doi: 10.1074/jbc.M101287200

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review of the last decade;British Journal of Cancer;2024-08-03

2. Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells;Frontiers in Cell and Developmental Biology;2023-10-26

3. Lenalidomide arrests cell cycle and modulates PD1-dependent downstream mTOR intracellular signals in melanoma cells;Melanoma Research;2023-07-12

4. Epimutations and Their Effect on Chromatin Organization: Exciting Avenues for Cancer Treatment;Cancers;2022-12-29

5. Beyond Surgical Treatment in Adenoid Cystic Carcinoma of the Head and Neck: A Literature Review;Cancer Management and Research;2022-06